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Abstract
Background Our previous study found that somatostatin
(SST) inhibited the intestinal inflammatory injury in a
macaque model of intestinal ischemia–reperfusion (IIR);
however, the underlying mechanism was unclear.
Aims The present study was aimed to investigate the
effects of SST on IFN-c and the systemic inflammatory
response after IIR.
Methods Fifteen macaques were randomly divided into
controls, IIR and SST? IIR groups. ELISA was performed
to measure IFN-c in ileum tissues, ileac epithelial cells
(IECs) and ileal lymphocytes, as well as the systemic levels
of IL-6, IL-1b, TNF-a and IFN-c in the peripheral circu-
lation and the portal vein. HE staining was performed to
evaluate morphological changes in vital organs. Immuno-
histochemistry was performed to identify the distribution
of IFN-c, CD4, CD8 and CD57 in the ileum.
Results After IIR, IFN-c level was significantly increased
in the IECs. IL-6, IL-1b and TNF-a were significantly
increased in both the portal vein and the peripheral circu-
lation; in contrast, IFN-c level was increased in the portal
vein alone. Prophylactic SST reversed the change in IFN-c
in the IECs and portal vein. SST led to an alleviation of the
pathological changes in systemic vital organs. The distri-
bution of CD4?, CD57? and CD8? cells was not positively
correlated with the secretion of IFN-c.
Conclusion IECs are the main source of IFN-c produc-
tion after IIR. SST may indirectly lead to mast cell deac-
tivation through the inhibition of IFN-c production by
IECs. Pretreatment with SST may be beneficial for pre-
venting a massive systemic inflammatory response in vital
organs after IIR.
Keywords Somatostatin  Intestinal ischemia–
reperfusion  Interferon-c  Macaques
Introduction
Intestinal ischemia–reperfusion (IIR) has been established as
an important pathophysiological process in severe trauma,
shock, severe acute pancreatitis, infection, organ transplan-
tation and other inflammatory-related conditions [1]. Clini-
cal and experimental studies performed during the past two
decades have identified the gut as the ‘‘motor’’ of multiple
organ dysfunction syndromes (MODS) in these critical
conditions [2–4]. This is a highly active area of research as
therapeutic approaches targeting the mechanisms to prevent
and cure MODS would be of great value. A common theme
of all these studies is that some element derived from the gut,
such as from the intestinal epithelium, the mucosal immune
system or commensal bacteria, contributes to critical ill-
nesses [4]. However, as basic and clinic research has
evolved, the mechanism by which the gastrointestinal tract
drives systemic inflammation remains unclear.
Intestinal mucosal mast cells (IMMCs) are considered as
one of the key initiators of the development of inflamma-
tion due to their participation in acute vasodilation, che-
mokine production, leukocyte trafficking, proinflammatory
cytokine signaling, the degradation of the extracellular
matrix, and immunomodulatory and counterinflammatory
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signaling [5–8]. Preferentially, these cells are located in the
perineuronal area, suggesting a potential interaction
between mast cells and neuropeptides within the intestinal
wall [6]. Somatostatin (SST), a multifunctional neuropep-
tide, is widely distributed throughout the central nervous
system and peripheral tissues. Because of its wide distri-
bution in the gastrointestinal tract and its wide variety of
biological functions, the tetradecapeptide SST in the gut
has attracted much attention. Our data and previous reports
by other researchers have led us to conclude that SST
inhibits the activation and degranulation of IMMC in vitro,
decreases microvascular permeability and edema formation
in the gut and leads to the alleviation of vital organ dys-
function in a rat model [9, 10]. Furthermore, for greater
relevance to human anatomy, physiology, biochemical
metabolism and pathophysiology of diseases, we used an
IIR macaque model to confirm that SST functions to pre-
vent massive inflammatory injury in the intestinal mucosa
[11]. The physiological functions of SST are initiated by its
interaction with specific membrane-bound, high-affinity
SST receptor (SSTR) on the surface of responsive cells.
Interestingly, although we found SSTR-1 expression on the
IMMCs of rats in a previous study [9], SSTR is not
expressed on the activated IMMCs of macaques. There are
insufficient data to interpret how SST modulates the
function of mast cells after IIR in macaques.
IFN-c, a regulatory cytokine that is critical for innate
and adaptive immunity, has been shown to be predomi-
nantly synthesized and released by CD4? Th1, CD8?
cytotoxic T lymphocytes and natural killer cells [12].
Increasing evidence indicates that IFN-c exerts pleiotropic
inflammatory effects through a specific receptor, leading to
intestinal inflammation [13, 14]. Previous studies have
shown that IFN-c is a negative regulator of mast cell
functions, including adhesion, degranulation and cytokine
release [15–17]. Research has also shown that IFN-c can
up-regulate the function of the FceRI signal on mast cells
through IFN-c receptors [18, 19]. FceRI is an important
signaling receptor in the activation process of intestinal
mucosal mast cells. The consequence of FceRI activation is
that the intestinal mucosal mast cells degranulate and
release histamine, IL-6, IL-13, IL-33 and other inflamma-
tory mediators [18, 19]. Although the role of IFN-c in
regulating mast cells is complex, these data confirm that
the functional responses of mast cells could be directly
regulated by IFN-c. Therefore, we were intrigued by the
idea that the indirect regulation of SST on mast cells might
be caused by a direct effect of SST on IFN-c.
This study was to examine the effects of SST on IFN-c
and the systemic inflammatory response during MODS,
thus elucidating the mechanism of SST in IMMCs. To
provide greater clinical relevance, a macaque IIR model
was used in this study.
Materials and Methods
Experimental Animals
Healthy adult rhesus macaques (4–7 years, body weight
6.9 ± 1.7 kg, male/female = 9/6) were obtained from the
Animal Center of Sichuan University. All the macaques were
maintained in the facility after a quarantine inspection. The
experiments in this study were performed in accordance with
the guidelines of the Sichuan University Institutional Animal
Care and Use Committee. All the animals were housed in an
environment with a temperature of 20–22 C with 12-h light/
dark cycles. The animals were fasted for 12 h, and drinking
water was withdrawn 2 h before the experiment began.
IIR Surgical Procedures in Macaques
The animals were anesthetized with xylazine (0.2 ml/kg,
i.m.) and maintained with diazepam (0.1 ml/kg, i.v.) and
carbrital (30 mg/kg, i.v.) as needed. A catheter was placed
in a peripheral vein to infuse 0.9 % saline and 20 g glucose
(0.1–0.2 ml/kg/min, i.v. gtt) for 24 h. A midline laparot-
omy of 5 cm in length was performed. Then, the superior
mesenteric artery (SMA) was isolated and occluded with a
microsurgical clip. After occlusion for 1 h, the clip was
removed, and intestinal perfusion was reestablished. The
animals were not provided any special volume resuscita-
tion during or after the SMA occlusion, and the infusion of
saline and glucose was maintained at the same speed as
described above. Venous blood samples were collected
again. The animals were killed 24 h after IIR via removal
of the vital organs under anesthesia overdose.
Experimental Grouping
Fifteen macaques were randomly divided into three groups,
with five animals (male/female = 3/2) in each group. In
the control group, the animals underwent a sham operation
with the same treatment described above, except that the
IIR procedure was not performed. In the IIR group, the
animals underwent the IIR procedure. In the SST?IIR
group, SST-14 (Serono Singapore Pte Ltd, Singapore) was
administered to the animals intravenously via a syringe
pump at a dosage of 5 lg/kg/h from 5 min before SMA
occlusion until the end of the experiment. The SST dosage
(5 lg/kg/h) of SST was based on the recommendation of
250 lg/h for human beings [20]. The other treatments for
this group were the same as those for the IIR group.
Morphological Study of Macaque Vital Organs
Specimens were removed from the colon, liver and lung of
each animal and were fixed with 10 % formaldehyde. The
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histologic sections were evaluated in a blinded fashion. For
the semiquantitative evaluation of inflammatory lesions in
the vital organs, ten arbitrary microscopic fields were
viewed in each sample. The scoring system was based on
the area of the inflammatory lesion: ?, \1/3 total area;
??, 1/3–2/3 total area; and ???, [2/3 total area. [11]
Disease score in one sample was calculated by the sum-
mary of the total score of 10 fields (?, 1; ??, 2; ???, 3).
Isolation of Intestinal Mucosa Epithelial Cells (IECs)
and Lamina Propria Lymphocytes (LPLs)
Intestinal epithelial cells (IECs) and lamina propria lym-
phocytes (LPLs) were isolated following a previously
described method [21, 22]. Briefly, the dissected terminal
parts of the ileum were immediately placed in cold Hanks’
fluid (pH 7.4) and treated with 1 mM DTT (Invitrogen,
CA, USA) for 15 min to remove mucus. Then, the samples
were cut into small pieces and placed into 20 ml EDTA
(Invitrogen, CA, USA) and 10 mM D-Hanks’ fluid (pH
7.4). The sample was shaken for 10–20 min at 37 C. After
the sediment from the tissue samples had settled, the
supernatant was collected, filtered and centrifuged three
times at 1,500 rpm at 4 C for 5 min. The supernatant was
discarded, and the sediment was gently resuspended in cold
Hanks’ fluid. Using this procedure, more than 95 % of the
cells were identified as mucosal epithelial cells, and their
identities were confirmed by alkaline phosphatase rapid
staining. The positive staining of intestinal epithelial cells
was indicated by a gray-black cell membrane. The cells
were shown to be alive by negative staining with
0.2 %trypan blue.
To isolate LPLs, the remaining tissues were cut into
1-mm pieces and incubated 2–3 times in 5 ml PBS con-
taining 2.5 mg collagenase D (Roche Applied Science,
Indianapolis, IN), 2.5 mg DNase (Sigma-Aldrich, St.
Louis, MO) and 15 mg dispase II (Roche Applied Science,
Indianapolis, IN) at 37 C for 20 min under slow rotation
until the samples were digested into invisible small pieces.
The supernatants were loaded on a Percoll gradient, and the
LPL was collected at the interface between 35 and 70 %
Percoll (GE healthcare, Sweden) after centrifugation at
4 C for 20 min at 1,000 g. Single cells suspended at
2 9 106 ml were cultured in RPMI 1,640 medium sup-
plemented with 10 % FCS and were stimulated with con-
canavalin A (5 mg/L) (Invitrogen, CA, USA) at 37 C in a
5 % CO2 incubator. After incubation for 24 h, the super-
natants were collected and stored at -70 C.
Effects of SST on IECs In Vitro
Isolated IECs were incubated in DMEM medium (10 %
bovine serum, 100 U/ml penicillin, 100 U/ml
streptomycin, 10 U/ml gentamycin) at 37 C for 3 h and
grown in a six-well plate with 1 9 106 cells/ml in each
well. The cells were incubated separately with (1) LPS
(10 lg/ml; Sigma, St Louis, MO, USA); (2) SST-14
(2.2 lM/ml, Sigma); and (3) LPS (10 lg/ml) ? SST
(2.2 lM/ml) for 24 h. Control wells were incubated with
DMEM medium only. After incubation, the supernatant of
each well was collected and stored at -70 C.
Protein Extraction from Colonic Mucosa and Cells
The mucosa was scraped from the terminal ileum of the
macaques at 4 C, and the cells were snap-frozen and
stored at -80 C. The frozen samples were homogenized
in a homogenization buffer (50 mM Tris–HCl, pH 7.2)
containing 150 mM NaCl, 1 mM Na3VO4, 1 mM PMSF
and a protease inhibitor cocktail (Sigma-Aldrich, St. Louis,
MO) using an ultrasonic homogenizer. Each homogenate
was centrifuged at 3,000 g for 10 min. The supernatants
were collected as total protein, and the protein concentra-
tion was measured using the Bio-Rad Protein Assay.
Determination of Cytokines by Enzyme-Linked
Immunosorbent Assay (ELISA)
The expression levels of IFN-c in sera from the peripheral
veins and portal veins, ileac mucosa protein, IECs and
LPLs, lymphocytes and IECs supernatant after incubation
were determined with an ELISA kit (R&D Systems, Inc.,
Minneapolis, USA) according to the manufacturer’s
instructions. The expression levels of IL-6, IL-1b and TNF-
a in sera from the peripheral veins and portal veins were
determined with an ELISA kit (R&D Systems, Inc., Min-
neapolis, USA) according to the manufacturer’s
instructions.
Visualization of IFN-c, CD4, CD8 and CD57
by Immunohistochemistry
Sections of the terminal ileum were deparaffinized and
microwaved for 15 min. For nonspecific blocking, 10 %
goat serum was added, and the sections were incubated for
20 min at room temperature. The following antibodies
were then added to individual sections: rabbit antihuman
IFN-c (polyclonal antibody, 1:200, Boster Bioagent Com-
pany, Beijing, China), and mouse antihuman CD4, CD8
and CD57 (monoclonal antibody, 1:100, Zymed, CA,
USA). After incubations with polyclonal antibodies for
120 min at 37 C and overnight at 4 C, the sections were
stained with a ready-to-use streptavidin–catalase immuno-
histochemical reagent system. The color reactions were
developed with diaminobenzidine (DAB; Zhongshan Bio-
agent Company, Beijing, China). A semiquantitative
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immunohistochemical analysis of the raw data was per-
formed with Image-Pro Plus 4.0 software to score inte-
grated optical density (IOD). Each value represented the
mean ± SD of five visual fields in which duplicate mea-
surements were made.
Statistical Analysis
All the quantitative data are presented as the mean ± SD
from the five animals in each group with duplicate mea-
surements in each animal. The data were analyzed using
SPSS (version 14.0; SPSS, Inc., Cary, NC, USA). The data
were evaluated with an ANOVA and confirmed using a
post hoc test for multiple comparisons. Significance was set
at p \ 0.05.
Results
Up-Regulation of IFN-c in IECs After IIR
To determine the level of IFN-c in gut injury after IIR, we
first performed immunohistochemistry and found a weak
staining for IFN-c in the terminal ileal epithelium of the
control group (Fig. 1a). After IIR, extremely strong posi-
tive staining for IFN-c was detected in the ileal epithelium.
Positive staining for IFN-c was observed in both the
cytoplasm and the membrane of IECs and in the lamina
propria (Fig 1a). Next, to determine which group of cells
leads to the excessive secretion of IFN-c in the intestinal
epithelium, we isolated IECs and LPLs, the two main



































































Fig. 1 Comparison of IFN-c
levels in normal, IIR and
SST?IIR intestines. Fifteen
macaques were randomly
divided into control, IIR and
SST?IIR groups.
a Immunohistochemical
analysis of IFN-c expression in
the terminal ileum of the
normal, IIR and SST?IIR
groups (9200 magnification).
Semiquantitative analysis of
these raw data was used to
measure the difference among
the three groups. Integrated
optical density (IOD), lower
panel. b Comparison of IFN-c
levels in extracted protein of
ileal tissue (tissue), intestinal
epithelial cells (IEC) and lamina
propria lymphocytes (LPLs) of
the normal, IIR and SST?IIR
groups. c Comparison of IFN-c
levels in the supernatant of
LPLs from the normal, IIR and
SST?IIR groups. In b, c, the
data were obtained by ELISA as
pg/mg total protein (TP) in the
tissue or pg/ml in the serum.
*Compared with the control
group, P \ 0.05. #Compared
with the IIR group, P \ 0.05
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by ELISA. Interestingly, the up-regulation of IFN-c in
IECs after IIR was confirmed by quantifying the extracted
protein expression (Fig. 1b). However, the IFN-c level in
the intestinal lymphocytes of the IIR group decreased
significantly (compared to that of the controls), both in the
extracted proteins of LPLs and in incubation supernatant of
intact LPLs (LPL-S) after stimulation (Fig. 1c). Addition-
ally, no significant difference in the IFN-c level in the total
ileum between the control and IIR group was revealed.
These data demonstrated that the increased expression of
IFN-c in epithelium occurs in IECs after IIR.
Elevated Level of IFN-c in the Portal Vein, but Not
in the Peripheral Circulation After IIR
Along with the up-regulation of IFN-c, the levels of other
proinflammatory cytokines, including IL-6, IL-1b and
TNF-a, increased significantly in the ileum of the IIR
group (Fig. 2). This finding indicates an exacerbation of
the proinflammatory status in the gut after IIR. To deter-
mine the influence of cytokines on the systemic inflam-
matory response, we measured the cytokine levels in both
the portal vein and the peripheral circulation. All the tested
cytokine levels, including IFN-c, IL-6, IL-1b and TNF-a,
were increased significantly in the portal vein after IIR.
The IL-6, IL-1b and TNF-a levels in the peripheral cir-
culation were also significantly increased after IIR (Fig. 2).
However, the IFN-c level in the peripheral circulation after
IIR was not significantly different from that of the control
group (Fig. 2).
Alleviation of Vital Organ Dysfunction by SST After
IIR
All the experimental animals treated with IIR developed
MODS, but none of the control animals did. Only one
macaque (1/5) in the SST?IIR group developed MODS
before being killed. There were obvious impairments of
vital organs, including the small intestines, liver, lungs and
kidneys in the animals treated with IIR compared with the
normal control group. After the intravenous injection of
SST, a significant improvement of these pathological
changes was observed (Fig. 3). The alleviation of intestinal
damages includes reduction in the degrees of intestinal
villous atrophy, tissue edema, inflammatory cell infiltration
and intestinal mucosal hemorrhage. The hepatic lobular
structure became more defined with less infiltration of
inflammatory cells. The tissue of the inter-alveolar space
appeared much thinner, with decreased inflammatory cells
infiltration and hyperemia. A reduced loss of epithelial
cells from the renal tubules, with less tubular structure
formation, was also observed. All these data support the
protective and anti-inflammatory role of SST after IIR in
macaques.
Down-Regulation of IFN-c in the IECs and Portal Vein,
but Not in Other Immune Cells, by SST After IIR
After pretreatment with SST, immunohistochemistry
showed that the IFN-c level in the intestinal epithelium was

































































Fig. 2 Comparison of cytokine
levels in portal vein and
peripheral circulation of normal,
IIR and SST?IIR macaques.
a IFN-c levels were
significantly increased in the
portal vein (PV) but not in the
peripheral circulation (PC),
after IIR. In b–d, the levels of
proinflammatory cytokines,
including IL-6, IL-1b and TNF-
a, were significantly increased
both in the PV and in the PC.
SST significantly inhibited the
secretion of cytokines. The data
were obtained by ELISA as pg/
ml in the serum. *Compared
with the control group,
P \ 0.05. # Compared with the
IIR group, P \ 0.05
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cytokine levels in the IECs also decreased significantly to
their normal levels, together with the IFN-c level in the
portal vein in the SST?IIR group (Fig. 1b). However, SST
did not alter the IFN-c down-regulation trend after IIR in
the LPLs or in the culture medium from the lymphocytes
after 24 h of incubation (Fig. 1b, c). Furthermore, no sig-
nificant differences were found in the total ileum tissue or
peripheral blood among the control, IIR and IIR ? SST
groups (Fig. 1b). These data provide evidence that SST
inhibited secretion of IFN-c in IECs, but not in lympho-
cytes after IIR.
In previous data, we reported that SST receptor subtype 2
was found in intestinal epithelium of macaques [11]. To
further confirm the direct role of SST on IECs, the level of































Fig. 3 Alleviating effect of SST on systemic inflammatory injury
after IIR. a HE staining of vital organs in the normal, IIR and
SST?IIR groups. The black arrows indicate infiltration by
inflammatory cells (9200 magnification). b Disease score of vital
organs in the normal, IIR and SST?IIR groups. *Compared with the
control group, P \ 0.05. #Compared with the IIR group, P \ 0.05
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IFN-c in isolated IECs was stimulated by LPS. SST signifi-
cantly reduced the levels of IFN-c induced by LPS (Fig. 4).
To further investigate any potential influence of SST on
IFN-c secreting by immune cells, we measured the expres-
sion of CD4? Th cells, CD8? Tc cells and CD57? natural
killer cells in terminal ileal mucosa using immunohisto-
chemistry. In a previous study, we had found that the SST
level in the ileum decreased significantly after IIR and
extrinsic SST reversed this change [11]. In the present study,
we found that CD4? cells were scattered throughout the
intestinal epithelium and lamina propria, but the number of
these cells was reduced significantly by the decreased level
of SST after IIR. Extrinsic SST did not change the expression
of CD4 (Fig. 5a, b). Normal CD8 ? cells were scattered
throughout the intestinal epithelium (but not in lamina pro-
pria) and disappeared after IIR. Prophylactic SST induced
the expression of CD8? and restored it to the normal level.
Compared to the IIR group, the trends of CD8? expression
was opposite to that of IFN-c in SST?IIR group (Fig. 5a, b).
CD57? cells were only scattered in the lamina propria of
epithelium in normal condition and increased significantly
after IIR. SST significantly increased the expression of
CD57?, which indicates the irrelevance of the change in
CD57? to that of IFN-c and SST in the ileum (Fig. 5a, b). All
these data provide evidence that the changes in the other
immune cells were not related to IFN-c secretion in the IIR
model (Fig. 6).
Discussion
Intestinal epithelial cells play a key role in intestinal
mucosal immunity. In the past, more attention has been
paid to the passive barrier function, which protects the
underlying tissues and nonspecific defenses secreted by
IECs, such as mucus, lysozyme and the transport of
secretory immunoglobulins. Now, there is a growing
appreciation that IECs release multiple cytokines, chemo-
kines and inflammatory mediators in response to antigenic
stimulus [23, 24]. After IIR-induced gut injury, numerous
bacteria invade IECs, which leads to bacterial transloca-
tion, the main pathogenesis of MODS [25, 26]. However,
little is known about the role of IECs in the secretion of
cytokines after IIR in humans. To our knowledge, this is
the first report to demonstrate that ileal epithelial cells are
an important producer of IFN-c in primates. Interestingly,
as SST significantly alleviated the gut injury in the
SST?IIR group, the IFN-c derived from IECs decreased
significantly. This finding suggests that IECs-derived IFN-
c plays a crucial role in the development of MODS. It is
worth noting that although lymphocytes, CD4? T cells,
CD8? T cells and CD57? natural killer cells have been
reported to be the main sources of IFN-c in intestinal
inflammation [12], a higher level of IFN-c secretion was
not observed in those cells in our IIR model.
Another important component of the intestinal mucosal
immune system is the mast cells, which derive from plu-
ripotent precursor cells in the bone marrow or hemato-
poietic tissue. After entering the intestinal mucosa, mast
cells mature under the influence of local microenviron-
mental conditions, and they localize preferentially next to
vascular nerve terminals in the lamina propria [6]. Inter-
estingly, receptors for IFN-c have been detected on both
mouse [27] and human [19] mast cells. In addition, the
stimulation of various mast cell populations with IFN-c in
both vitro and in vivo models has been reported to mod-
ulate the degranulation and activation of mast cells [19,
28]. Recently, it was reported that the mast cell expression
of IFN-c R was required for the optimal development of
many features, including inflammation, local remodeling
and the markedly increased expression of several cyto-
kines, chemokines, and markers of an alternatively acti-
vated macrophage response [18]. Here, we showed an
inverse relationship between IFN- c and SST in the intes-
tinal epithelium. Based on our previous and present works,
we hypothesize that SST modulates IFN-c in the normal
intestinal mucosa, but mast cells are not activated. After
IIR, along with the reduction in the SST level, the IFN-c
derived from IECs was significantly increased. Under such
microenvironmental conditions, mast cells were reacti-
vated, which resulted in an excessive natural immune
response. The prophylactic supplementation of SST indi-
rectly prevented intestinal mucosal mast cell degranulation
by reducing the secretion of IFN-c by IECs, thus pre-
venting multiple organ dysfunction syndromes. Most























Fig. 4 Inhibition of IFN-c in IECs by SST in vitro isolated IECs
from macaques was incubated with LPS (10 lg/ml), SST-14 (2.2 lM/
ml) and LPS ? SST for 24 h, respectively. The supernatant was
collected, and the IFN-c level was measured by ELISA. *Compared
with the normal control group, P \ 0.05. #Compared with the LPS
group, P \ 0.05
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may indirectly modulate mast cell function through the
inhibition of IFN-c secretion by intestinal epithelial cells.
The IFN-c level was significantly increased in the
intestinal wall after IIR. However, the role of IFN-c in the
systemic inflammatory response remains controversial. In
the present study,the proinflammatory cytokines, IL-6, IL-
1b and TNF-a, were significantly increased in both the
portal vein and in the peripheral blood after IIR. This result
is consistent with those from rodent and human models,
supporting the theory that the gut is the motor of systemic
inflammation [4, 11, 29]. However, although the IFN-c
level was significantly increased in the portal vein, it was
normal in the peripheral blood, suggesting that the increase
in IFN-c derived from intestinal epithelial cells was
attenuated in the liver and lung. Hence, we believe that the
liver should be considered as the first stage of physiological
protection in the systemic inflammatory response. Then,
the remaining IFN-c that is not catabolized by the liver
flows into the pulmonary circulation, successively via the
hepatic vein, inferior vena cava, right atrium, and right
ventricle. Interestingly, the human lung contains abundant
mast cells that exhibit similar subtypes to those in the
intestine [for instance, more than 90 % are MCc subtype
(i.e., only tryptase containing)]. Therefore, IFN-c may
easily target , activate mast cells in the lung and then cause
the acute lung injury or ARDS [30]. This may partly
explain why the lung is the first and most common organ to
be injured in MODS. In the other words, the lung should be
recognized as the second gate of physiological protection
organ in the systemic inflammatory response. Due to its
experience in the metabolism and consumption of these














































Fig. 5 Expression of CD4, CD8, CD57 in normal, IIR and SST?IIR
intestines. a Immunohistochemical staining of CD4, CD8 and CD57
in normal, IIR and SST?IIR intestines. b Semiquantitative analysis of
these raw data. The integrated optical density (IOD) was used to
measure the difference. *Compared with the control group, P \ 0.05.
#Compared with the IIR group, P \ 0.05
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peripheral circulation. Therefore, pathological injuries to
other organs, such as the kidney, may not be associated
with IFN-c.
In conclusion, we demonstrated that the ileal epithelial
cells were the main source of IFN-c production in the
intestinal mucosa after IIR. Moreover, this function was
negatively regulated by SST, leading to an alleviation of
the systemic inflammatory response. These results, together
with the finding concerning IFN-c, mast cells and SST,
may not only enhance the current understanding of intes-
tinal mucosal innate immunity but also provide new con-
cept or opportunity for the prevention and treatment of
MODS.
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